Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

50.56
Delayed Data
As of Aug 30
 -0.19 / -0.37%
Today’s Change
48.01
Today|||52-Week Range
66.55
-22.97%
Year-to-Date
Your Complete Guide to the Generic Drug Industry
Aug 29 / Zacks.com - Paid Partner Content
Why Mylan's EpiPen Is Sparking "Epi-Rage"
Aug 25 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSp...
Aug 29 / Zacks.com - Paid Partner Content
Teva Stock Gains, Leerink: Despite Patent Loss, No Generic Competition Until 2018
Aug 25 / TheStreet.com - Paid Partner Content
Generic EpiPen coming for $300, as Mylan responds to outrage
Aug 29 / CNNMoney.com
Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem
Aug 25 / TheStreet.com - Paid Partner Content
Allergan: An Undervalued Powerhouse
Aug 28 / GuruFocus News - Paid Partner Content
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
Aug 25 / Zacks.com - Paid Partner Content
A Comprehensive Look at Dividend Growth Stock Valuations Sector by Sector: Part 2
Aug 26 / GuruFocus News - Paid Partner Content
Why EpiPen, Why Now: Analysts Explain the Timing of Mylan's Trouble
Aug 24 / TheStreet.com - Paid Partner Content
Pharma Has History of Price Gouging, Mylan Should Be No Surprise
Aug 26 / TheStreet.com - Paid Partner Content
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Aug 24 / MotleyFool.com - Paid Partner Content
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug 24 / TheStreet.com - Paid Partner Content
Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco
Aug 26 / TheStreet.com - Paid Partner Content
Teva Stock Drops After Patent Invalidated
Aug 24 / TheStreet.com - Paid Partner Content
EpiPen outrage may fuel cheap generic in 2017
Aug 26 / CNNMoney.com
Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
Aug 22 / Zacks.com - Paid Partner Content
FTC Details Concerns on Generic Drug Company Mergers
Aug 26 / TheStreet.com - Paid Partner Content
Top Research Reports for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
4 Stocks That Billionaires Wanted Little to Do With in the Second Quarter
Aug 26 / MotleyFool.com - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Positive Phase III Results on MS Drug
Aug 26 / Zacks.com - Paid Partner Content